<DOC>
	<DOC>NCT02333708</DOC>
	<brief_summary>To demonstrate that microparticles (MPs), having a powerful procoagulant potential, are in larger amounts in the blood of patients with histologically proven giant cell arteritis (GCA), compared with patients matched for age, sex and with or without inflammatory syndrome.</brief_summary>
	<brief_title>Study of Circulating Microparticles in Giant Cell Arteritis</brief_title>
	<detailed_description />
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<criteria>For GCA group: Men and women â‰¥ 18 years of age Patient affiliated to social security regimen Informed and having signed the consent form to take part in the study. Diagnosis of GCA, meeting at least 3 of the following 5 American College of Rheumatology (ACR) criteria for the diagnosis of GCA, including inflammatory syndrome and having Either temporal artery biopsy showing characteristic GCA abnormality Or inflammatory arteritis on imaging examination Persons under protection of the court or guardianship Inability to understand or to follow study procedures Dementia cancer diagnosed within the previous 5 years (except for nonmelanoma skin cancer or in situ carcinoma of the cervix)noncontributory or inconclusive temporal artery biopsy Any conditions that might interfere with MPs level: diabetes, recent endoarterial gesture, current treatment with corticosteroids. Participation in another ongoing clinical trial Current anticoagulant therapy Active infectious disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>